Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 4 | |
Outperform | 9 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 13 analysts offering 12 month price targets for Crinetics Pharmaceuticals Inc have a median target of 70.00, with a high estimate of 97.00 and a low estimate of 48.00. The median estimate represents a 29.92% increase from the last price of 53.88.
High | 80.0% | 97.00 |
Med | 29.9% | 70.00 |
Low | -10.9% | 48.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate | -0.24% |
Average growth rate | -15.28% |
More ▼
Revenue history & estimates in USD
Average growth rate | -67.55% |
Average growth rate | +412.10% |
More ▼